Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BioNuclear Scandinavia AB
AB
Dissolved
Org 5562450642
Wholesale of chemical products · NACE 4675
Est. 1984
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2019
SEK 0
EBITDA margin
—
+5% vs 2018
Equity ratio
64.7%
Financial strength
Net profit 2019
SEK 77K
+485% vs 2018
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2016
0M
0%
2017
0M
0%
2018
0M
0%
2019
Key figures
Annual report 2019
Revenue
SEK 0
—
EBITDA
SEK -21K
+5%
Net profit
SEK 77K
+485%
Total assets
SEK 669K
+10%
Equity
SEK 433K
+21%
Employees
0
—
Company information
Legal name
BioNuclear Scandinavia AB
Org number
5562450642
Legal form
Aktiebolag
NACE code
4675 · Wholesale of chemical products
Founded
15 maj 1984
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-08-31
Financial year
January – December
Company purpose
Bolaget skall bedriva agenturförsäljning av biokemikalier, ävensom idka därmed förenlig verksamhet.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of chemical products
Companies in
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
0M
2019
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
0M
2019
Income statement
SEK thousands
Item
2016
2017
2018
2019
Revenue
0
0
0
0
Staff expenses
—
—
—
—
EBITDA
−44
−22
−22
−21
Depreciation & amort.
−0
−0
−0
−0
EBIT
−44
−22
−22
−21
Net financials
4
−9
2
98
Profit before tax
−40
−32
−20
77
Tax
−0
−0
−0
−0
Net profit
−40
−32
−20
77
Balance sheet
SEK thousands
Item
2016
2017
2018
2019
Total assets
858
627
606
669
Equity
608
376
357
433
Long-term debt
0
0
0
0
Short-term debt
250
250
249
236
Total debt
250
250
249
236
Financial ratios
5-year trend
EBITDA margin
-2100000.0%
This company
15.8%
Market median
-13291239% vs market
2016
2019
Equity ratio
64.7%
This company
38.2%
Market median
+69% vs market
2016
2019
Return on equity
17.8%
This company
18.4%
Market median
+3% vs market
2016
2019
Net profit margin
7700000.0%
This company
8.1%
Market median
+95061628% vs market
2016
2019
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2016
2019
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
2016
2019
Annual reports & filings
Annual report 2019
Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
View
PDF
Annual report 2017
Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
View
PDF
Annual report 2016
Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Former (2)
KT
Kari Torborg Blomqvist Eriksson
Board of Directors
2020 – 2021
LE
Lars Erik Vilhelm Eriksson
Deputy Board Member
2020 – 2021
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of BioNuclear Scandinavia AB also hold positions in
0
other companies.
Person
Role here
Other companies
Kari Torborg Blomqvist Eriksson
Board of Directors
0 companies
Lars Erik Vilhelm Eriksson
Deputy Board Member
0 companies